We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Global Diagnostic Labs Market Driven by Increased POCT Testing and Smart Portable Devices

By LabMedica International staff writers
Posted on 13 Sep 2022

Clinical diagnostics are beneficial for diagnosing prevalent chronic diseases and are valuable in disease prevention, detection, and treatment. More...

Clinical diagnostics help identify early warning signs and individual risk factors, and create new opportunities for prevention and early intervention. As diagnostic chains and insurance coverage expand, clinical laboratory tests are becoming more common due to the increasing demand for early detection of diseases and earliest possible search for causes to receive appropriate therapy. Diagnostic laboratories, which are equipped with apparatus and reagents for performing diagnostic tests, play an important role in reducing the widespread impact of certain diseases. Hence, the increasing prevalence of chronic diseases, growing use of point-of-care diagnostics, and rising healthcare expenditures are fueling the growth of the diagnostic labs market. The global diagnostic labs market is projected grow at a CAGR of 8.3% from over USD 297 billion in 2021 to more than USD 514 billion by 2028.

These are the latest findings of Research and Markets (Dublin, Ireland), a market research firm.

The COVID-19 pandemic has led to increased funding and tests, which boosted the growth of the diagnostic labs market. Millions of tests were carried out worldwide to identify COVID-19 infection and stop the spread of the SARS-CoV-2 virus. Due to the increased burden of COVID-19 testing or drop in demand for other types of diagnostic tests, several laboratories had stopped performing other diagnostic procedures. Various testing laboratories entered the diagnostic labs market and significantly contributed to its further growth. Thus, the increasing number of SARS-CoV-2 tests due to a constant rise in COVID-19 infections and government funding is expected to result in a surge in demand for testing and propel the growth of the global diagnostic labs market.

Diagnostics laboratories have witnessed a digital transformation, and the modern laboratory has dramatically changed how tests are performed. As the technological revolution in labs continues, there is a growing need to provide a modern, quality-driven digital approach to laboratory operations that offers convenience, innovation, and reliability. Innovative technologies have made POCT devices portable and also improved sampling techniques, so they are minimally disruptive. POCT technology's relatively user-friendly nature is mainly due to advances in disposable test cartridges and microprocessor-based analyzers. Several such advances are poised to change the industry testing paradigm through greater speed, quality, efficiency, and scalability to better guide patient care.

The healthcare system is increasingly recognizing the value that labs can play by becoming more of a clinical decision-making engine, helping patients conduct tests at home and physicians interpreting results and diagnosing and monitoring patients more accurately and faster. The smart lab market includes proprietary robotic platforms, automated tools, software-as-a-service (SaaS), mobile apps, and other digital solutions that support operations, data management, and analytics across the entire value chain in diagnostic labs and promote the growth the diagnostic labs market.

The ecosystem to support the growth of smart labs is maturing, and several technology start-ups and prominent commercial players are already developing products and solutions targeting the specific areas for pre-and post-analytical surgeries and related areas, including smart procurement and remote monitoring, and predictive maintenance. Increasing testing volumes, cost pressures, and distributed labs are forcing traditional participants to leverage converging technologies such as robotics, Artificial Intelligence (AI), big data, Inter of Things (IoT), and cloud technologies to move from static, fragmented operations and tools to dynamic and value-driven practices, making diagnostic results more accurate and faster.

Related Links:
Research and Markets 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Shaking Incubator
Corning LSE 71L
New
Multilevel Whole Blood Calibrator Set
6PLUS1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Schematic overview of the deep learning-based circulating exosome analysis for lung cancer detection (Photo courtesy of Chuan Xu, Cheng Jiang)

Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer

Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more

Pathology

view channel
Image: The Aiforia Breast Cancer Grading AI solution is CE-IVD marked (Photo courtesy of Aiforia Technologies)

Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy

Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.